Cambrex to Double Size of Edinburgh Solid Form Screening Facility
July 30, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering
June 26, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer
June 25, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., June 25, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site
June 04, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex to Present at Upcoming Investor Conferences in June
May 29, 2019 10:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Reports First Quarter 2019 Financial Results
May 02, 2019 06:40 ET
|
Cambrex Corporation
- Acquired Avista Pharma Solutions, broadening capabilities, enhancing revenue growth and expanding customer base - - Reaffirms full year financial guidance - - Conference call at 8:30 a.m. ET on...
Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019
April 30, 2019 10:45 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across...
Cambrex Completes New Quality Control Laboratory for Generic API Development in Milan
April 23, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across...
Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA
April 10, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 10, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across...
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
March 26, 2019 08:00 ET
|
Cambrex Corporation
EAST RUTHERFORD, N.J., March 26, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across...